Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-002319

CEO and CFO bought 1,800 shares at $29.83 ($53,694)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Patel Snehal CEO and CFO 2026-01-13 Purchase +1,800 $29.83 $53,694 5,604,102 D
Open-market purchases · 1,800 sh · avg $29.83 · $53,694
Loading xslF345X05/ownership.xml…